On December 23, 2024, the Stochastic Oscillator for ALSMY moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Momentum Indicator moved above the 0 level on December 05, 2024. You may want to consider a long position or call options on ALSMY as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
ALSMY moved above its 50-day moving average on December 04, 2024 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALSMY advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ALSMY turned negative on December 20, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALSMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ALSMY broke above its upper Bollinger Band on December 10, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALSMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.964) is normal, around the industry mean (1.783). P/E Ratio (0.000) is within average values for comparable stocks, (19.465). ALSMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.809). Dividend Yield (0.013) settles around the average of (0.040) among similar stocks. P/S Ratio (0.498) is also within normal values, averaging (3.387).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALSMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Industry Railroads
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IUSCX | 12.46 | 0.03 | +0.24% |
Fisher IIG US Sm Cap Eq | |||
GLRIX | 22.04 | 0.04 | +0.18% |
James Balanced: Golden Rainbow Instl | |||
DEVIX | 69.85 | 0.12 | +0.17% |
Delaware Small Cap Value Instl | |||
CFIAX | 13.88 | 0.02 | +0.14% |
Columbia Flexible Capital Income A | |||
NWSAX | 13.09 | -0.08 | -0.61% |
Nationwide Small Company Growth A |
A.I.dvisor tells us that ALSMY and AOMFF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALSMY and AOMFF's prices will move in lockstep.
Ticker / NAME | Correlation To ALSMY | 1D Price Change % | ||
---|---|---|---|---|
ALSMY | 100% | N/A | ||
AOMFF - ALSMY | 32% Poorly correlated | -1.04% | ||
CNI - ALSMY | 24% Poorly correlated | +1.28% | ||
TRN - ALSMY | 24% Poorly correlated | -1.65% | ||
WAB - ALSMY | 23% Poorly correlated | -0.82% | ||
GBX - ALSMY | 21% Poorly correlated | -0.67% | ||
More |